ARCHIVES

FDA Approves Arranon For Leukemia And Lymphoma

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | December 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

In Brief: NCI Awards $1.2 Million To Mt. Sinai To Establish Specialized Cancer Center

July 26, 1974

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

In Brief: “The Journal” to Mae its Appearance In Jan., With Wittes As Editor; Manuscripts Solicited

October 16, 1987